The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Collaboration with Theodora Foundation 2014
Invest for children has commited for the third consecutive year to finance all the work from one of the Doctores Sonrisa of Fundación Theodora during one year. More than 1,500…
see project 
